Guangzhou Baiyunshan Pharmaceutical Holdings Company Statistics

Total Valuation

Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of HKD 44.75 billion. The enterprise value is 43.95 billion.

Market Cap	44.75B
Enterprise Value	43.95B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 13, 2024

Share Statistics

Guangzhou Baiyunshan Pharmaceutical Holdings Company has 1.63 billion shares outstanding. The number of shares has increased by 0.00% in one year.

Shares Outstanding	1.63B
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	19.72%
Float	875.04M

Valuation Ratios

The trailing PE ratio is 7.07 and the forward PE ratio is 6.71. Guangzhou Baiyunshan Pharmaceutical Holdings Company's PEG ratio is 13.77.

PE Ratio	7.07
Forward PE	6.71
PS Ratio	0.35
PB Ratio	0.74
P/FCF Ratio	n/a
PEG Ratio	13.77

Financial Ratio History

Enterprise Valuation

EV / Earnings	10.78
EV / Sales	0.53
EV / EBITDA	8.40
EV / EBIT	9.53
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 36.43.

Current Ratio	1.52
Quick Ratio	1.14
Debt / Equity	36.43
Debt / EBITDA	2.85
Debt / FCF	n/a
Interest Coverage	9.89

Financial Efficiency

Return on equity (ROE) is 10.90% and return on invested capital (ROIC) is 5.33%.

Return on Equity (ROE)	10.90%
Return on Assets (ROA)	3.54%
Return on Capital (ROIC)	5.33%
Revenue Per Employee	2.86M
Profits Per Employee	141,747
Employee Count	28,048
Asset Turnover	1.01
Inventory Turnover	6.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.09% in the last 52 weeks. The beta is 0.55, so Guangzhou Baiyunshan Pharmaceutical Holdings Company's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-19.09%
50-Day Moving Average	19.91
200-Day Moving Average	20.68
Relative Strength Index (RSI)	23.45
Average Volume (20 Days)	580,519

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of HKD 82.29 billion and earned 4.08 billion in profits. Earnings per share was 2.51.

Revenue	82.29B
Gross Profit	14.63B
Operating Income	4.61B
Pretax Income	5.17B
Net Income	4.08B
EBITDA	5.23B
EBIT	4.61B
Earnings Per Share (EPS)	2.51

Full Income Statement

Balance Sheet

The company has 17.71 billion in cash and 14.92 billion in debt, giving a net cash position of 2.79 billion or 1.72 per share.

Cash & Cash Equivalents	17.71B
Total Debt	14.92B
Net Cash	2.79B
Net Cash Per Share	1.72
Equity (Book Value)	40.96B
Book Value Per Share	23.97
Working Capital	19.01B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 17.78%, with operating and profit margins of 5.60% and 4.95%.

Gross Margin	17.78%
Operating Margin	5.60%
Pretax Margin	6.28%
Profit Margin	4.95%
EBITDA Margin	6.36%
EBIT Margin	5.60%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 4.96%.

Dividend Per Share	0.88
Dividend Yield	4.96%
Dividend Growth (YoY)	1.24%
Years of Dividend Growth	6
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	4.96%
Earnings Yield	14.15%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a